The story of the erectile dysfunction drug presents a complex picture for investors. While the initial launch generated substantial profits, the end of its exclusive rights opened the avenue to cheaper competitors, https://socialwoot.com/story23560128/viagra-and-the-pharmaceutical-industry-a-risky-investment